Epithelial cells are charged with protection at barrier sites, but whether this normally beneficial response might sometimes become dysfunctional still needs definition. Here, we recognized a pattern of imbalance marked by basal epithelial cell growth and differentiation that replaced normal airspaces in a mouse model of progressive postviral lung disease due to the Sendai virus. Single-cell and lineage-tracing technologies identified a distinct subset of basal epithelial stem cells (basal ESCs) that extended into gas-exchange tissue to form long-term bronchiolar-alveolar remodeling regions. Moreover, this cell subset was selectively expanded by crossing a cell-growth and survival checkpoint linked to the nuclear-localized alarmin IL-33 that was independent of IL-33 receptor signaling and instead connected to autocrine chromatin accessibility. This mechanism creates an activated stem-progenitor cell lineage with potential for physiological or pathological function. Thus, conditional loss of Il33 gene function in basal epithelial cells disrupted the homeostasis of the epithelial barrier at skin and gut sites but also markedly attenuated postviral disease in the lung based on the downregulation of remodeling and inflammation. Thus, we define a basal ESC strategy to deploy innate immune machinery that appears to overshoot the primordial goal of self-defense. Our findings reveal new targets to stratify and correct chronic and often deadly postviral disease.
Kangyun Wu, Kenji Kamimoto, Yong Zhang, Kuangying Yang, Shamus P. Keeler, Benjamin J. Gerovac, Eugene V. Agapov, Stephen P. Austin, Jennifer Yantis, Kelly A. Gissy, Derek E. Byers, Jennifer Alexander-Brett, Christy M. Hoffmann, Matthew Wallace, Michael E. Hughes, Erika C. Crouch, Samantha A. Morris, Michael J. Holtzman
Title and authors | Publication | Year |
---|---|---|
Respiratory long COVID in aged hamsters features impaired lung function post-exercise with bronchiolization and fibrosis
Heydemann L, Ciurkiewicz M, Störk T, Zdora I, Hülskötter K, Gregor KM, Michaely LM, Reineking W, Schreiner T, Beythien G, Volz A, Tuchel T, Meyer zu Natrup C, Schünemann LM, Clever S, Henneck T, von Köckritz-Blickwede M, Schaudien D, Rohn K, Schughart K, Geffers R, Kaneko MK, Kato Y, Gross C, Amanakis G, Pavlou A, Baumgärtner W, Armando F |
Nature Communications | 2025 |
SMARCA4 regulates inducible BRD4 genomic redistribution coupling intrinsic immunity and plasticity in epithelial injury-repair
Xu X, Brasier AR |
Nucleic Acids Research | 2025 |
Mitogen-activated protein kinase-guided drug discovery for post-viral and related types of lung disease
Holtzman MJ, Zhang Y, Wu K, Romero AG |
European Respiratory Review | 2024 |
A nasal cell atlas reveals heterogeneity of tuft cells and their role in directing olfactory stem cell proliferation.
Ualiyeva S, Lemire E, Wong C, Perniss A, Boyd AA, Avilés EC, Minichetti DG, Maxfield A, Roditi R, Matsumoto I, Wang X, Deng W, Barrett NA, Buchheit KM, Laidlaw TM, Boyce JA, Bankova LG, Haber AL |
Science Immunology | 2024 |
MAPK13 controls structural remodeling and disease after epithelial injury
Wu K, Zhang Y, Mao D, Iberg CA, Yin-Declue H, Sun K, Keeler SP, Wikfors HA, Young D, Yantis J, Austin SR, Byers DE, Brody SL, Crouch EC, Romero AG, Holtzman MJ |
2024 | |
A correctable immune niche for epithelial stem-cell reprogramming and post-viral lung diseases
Kangyun Wu, Yong Zhang, Huiqing Yin-DeClue, Kelly Na Sun, Dailing Mao, Kuangying Yang, Stephen Austin, Erika Crouch, Steven L Brody, Derek E. Byers, Christy Hoffmann, Michael Hughes, Michael J. Holtzman |
Journal of Clinical Investigation | 2024 |
IL-33: Friend or Foe in Transplantation?
Hassan GF, Cohen LS, Alexander-Brett J |
The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation | 2024 |
Cell–cell interactions and communication dynamics in lung fibrosis
Xie T, Liang J, Stripp B, Noble PW |
Chinese Medical Journal Pulmonary and Critical Care Medicine | 2024 |
A first-in-kind MAPK13 inhibitor that can correct stem cell reprogramming and post-injury disease
Zhang Y, Wu K, Mao D, Iberg CA, Yin-Declue H, Sun K, Wikfors HA, Keeler SP, Li M, Young D, Yantis J, Crouch EC, Chartock JR, Han Z, Byers DE, Brody SL, Romero AG, Holtzman MJ |
bioRxiv | 2024 |
The post-viral GPNMB(+) immune niche persists in long-term Covid, asthma, and COPD.
Wu K, Zhang Y, Yin-DeClue H, Sun K, Mao D, Crouch EC, Byers DE, Holtzman MJ |
medRxiv : the preprint server for health sciences | 2024 |
MrgprA3 neurons drive cutaneous immunity against helminths through selective control of myeloid-derived IL-33.
Inclan-Rico JM, Napuri CM, Lin C, Hung LY, Ferguson AA, Liu X, Wu Q, Pastore CF, Stephenson A, Femoe UM, Musaigwa F, Rossi HL, Freedman BD, Reed DR, Macháček T, Horák P, Abdus-Saboor I, Luo W, Herbert DR |
Nature immunology | 2024 |
Lung remodeling regions in long-term Covid-19 feature basal epithelial cell reprogramming.
Wu K, Zhang Y, Austin SR, Declue HY, Byers DE, Crouch EC, Holtzman MJ |
The American Journal of Pathology | 2023 |
COVID-19 and influenza infection mediate distinct pulmonary cellular and transcriptomic changes.
Chenxiao Wang, Mst Khatun, Zhe Zhang, Michaela Allen, Zheng Chen, Calder Ellsworth, Joshua Currey, Guixiang Dai, Di Tian, Konrad Bach, Xiao-Ming Yin, Vicki Traina-Dorge, Jay Rappaport, Nicholas Maness, Robert Blair, Jay Kolls, Derek Pociask, Xuebin Qin |
Communications biology | 2023 |
An alternative mechanism for skeletal muscle dysfunction in long-term post-viral lung disease
Martin RA, Keeler SP, Wu K, Shearon WJ, Patel D, Li J, Hoang M, Hoffmann CM, Hughes ME, Holtzman MJ |
AJP Lung Cellular and Molecular Physiology | 2023 |
A new MAPK13-guided inhibitor for respiratory inflammation and mucus production
Keeler SP, Wu K, Zhang Y, Mao D, Li M, Iberg CA, Austin SR, Glaser SA, Yantis J, Podgorny S, Brody SL, Chartock JR, Han Z, Byers DE, Romero AG, Holtzman MJ |
2023 | |
A Deep View of the Biological Property of Interleukin-33 and Its Dysfunction in the Gut
Wang Y, He C, Xin S, Liu X, Zhang S, Qiao B, Shang H, Gao L, Xu J |
International journal of molecular sciences | 2023 |
Lung Science Conference highlights 2023: Post-viral lung diseases – from basic immunology to clinical phenotypes and therapy
Cuevas Ocaña S, DeSanti C, Daly K, Shrees C, László N, Bellinghausen C, Voss C, Cruz J |
Breathe | 2023 |
Unpacking the complexity of nuclear IL-33 (nIL-33): a crucial regulator of transcription and signal transduction
Wang Z, Tang N |
Journal of Cell Communication and Signaling | 2023 |
“MrgprA3 neurons selectively control myeloid-derived cytokines for IL-17 dependent cutaneous immunity”
Inclan-Rico JM, Napuri CM, Lin C, Hung LY, Ferguson AA, Wu Q, Pastore CF, Stephenson A, Femoe UM, Rossi HL, Reed DR, Luo W, Abdus-Saboor I, Herbert DR |
Research square | 2023 |
A potent MAPK13-14 inhibitor prevents airway inflammation and mucus production
Keeler SP, Wu K, Zhang Y, Mao D, Li M, Iberg CA, Austin SR, Glaser SA, Yantis J, Podgorny S, Brody SL, Chartock JR, Han Z, Byers DE, Romero AG, Holtzman MJ |
AJP Lung Cellular and Molecular Physiology | 2023 |
Is IL-1β a Target for Reducing Hospitalization of Infants Infected with Respiratory Syncytial Virus?
Y Mebratu, Y Tesfaigzi |
American journal of respiratory cell and molecular biology | 2022 |
Clinical, radiological, and pathological findings in patients with persistent lung disease following SARS-CoV-2 infection
C Ravaglia, C Doglioni, M Chilosi, S Piciucchi, A Dubini, G Rossi, F Pedica, S Puglisi, L Donati, S Tomassetti, V Poletti |
The European respiratory journal : official journal of the European Society for Clinical Respiratory Physiology | 2022 |
Nasally delivered interferon-λ protects mice against infection by SARS-CoV-2 variants including Omicron
Z Chong, C Karl, P Halfmann, Y Kawaoka, E Winkler, S Keeler, M Holtzman, J Yu, M Diamond |
Cell Reports | 2022 |
Chloride channel accessory 1 gene deficiency causes selective loss of mucus production in a new pig model
Keeler SP, Yantis J, Gerovac BJ, Youkilis SL, Podgorny S, Mao D, Zhang Y, Whitworth KM, Redel B, Samuel MS, Wells KD, Prather RS, Holtzman MJ |
AJP Lung Cellular and Molecular Physiology | 2022 |
Intermediary Role of Lung Alveolar Type 1 Cells in Epithelial Repair upon Sendai Virus Infection
Hernandez BJ, Cain MP, Lynch AM, Flores JR, Tuvim MJ, Dickey BF, Chen J |
American journal of respiratory cell and molecular biology | 2022 |
Alveolar Repair after Viral Injury: A Tale of Two Cell Types
Kass-Gergi S, Vaughan AE |
American journal of respiratory cell and molecular biology | 2022 |
Lung remodeling regions in long-term Covid-19 feature basal epithelial cell reprogramming
Wu K, Zhang Y, Austin SR, Declue HY, Byers DE, Crouch EC, Holtzman MJ |
2022 | |
An alternative mechanism for skeletal muscle dysfunction in long-term post-viral lung disease
Martin RA, Keeler SP, Wu K, Shearon WJ, Patel D, Hoang M, Hoffmann CM, Hughes ME, Holtzman MJ |
2022 | |
Prevalence and Mechanisms of Mucus Accumulation in COVID-19 Lung Disease.
Kato T, Asakura T, Edwards CE, Dang H, Mikami Y, Okuda K, Chen G, Sun L, Gilmore RC, Hawkins P, De la Cruz G, Cooley MR, Bailey AB, Hewitt SM, Chertow DS, Borczuk AC, Salvatore S, Martinez FJ, Thorne LB, Askin FB, Ehre C, Randell SH, O'Neal WK, Baric RS, Boucher RC |
American journal of respiratory and critical care medicine | 2022 |
Full-length IL-33 augments pulmonary fibrosis in an ST2-and Th2-independent, non-transcriptomic fashion
Luzina IG, Lockatell V, Courneya JP, Mei Z, Fishelevich R, Kopach P, Pickering EM, Kang PH, Krupnick AS, Todd NW, Vogel SN, Atamas SP |
Cellular Immunology | 2022 |
Nuclear IL-33 as a growth and survival agent within basal cells
Harold Chapman |
Journal of Clinical Investigation | 2021 |
Interleukin (IL)-33 Immunobiology in Asthma and Airway Inflammatory Diseases
Gaurav R, Poole JA |
Journal of Asthma | 2021 |